SPONSOR

University of Maryland, Baltimore

Total Trials

Recruiting

Phases

Phase 2, Phase 1, Phase 4, EARLY_Phase 1

Conditions studied: Small-cell Lung Cancer Small Cell Lung Carcinoma Head and Neck Cancer Head and Neck Squamous Cell Carcinoma Oropharynx Cancer Oropharynx Squamous Cell Carcinoma HPV Positive Oropharyngeal Squamous Cell Carcinoma Polycystic Kidney Disease Alveolar Ridge Augmentation Obesity

University of Maryland, Baltimore is a clinical research sponsor with 17 registered studies on ClinicalTrials.gov, of which 17 are actively recruiting participants. Research covers conditions including Small-cell Lung Cancer, Small Cell Lung Carcinoma, Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma.

The trial portfolio spans Phase 2, Phase 1, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — University of Maryland, Baltimore

How many clinical trials has University of Maryland, Baltimore sponsored?

ClinicalMetric currently tracks 17 clinical trials sponsored by University of Maryland, Baltimore, of which 17 are actively recruiting participants. These trials cover conditions including Small-cell Lung Cancer, Small Cell Lung Carcinoma, Head and Neck Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does University of Maryland, Baltimore research focus on?

University of Maryland, Baltimore clinical trials span Small-cell Lung Cancer, Small Cell Lung Carcinoma, Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma, Oropharynx Cancer, and additional conditions. The research pipeline includes Phase 2, Phase 1, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a University of Maryland, Baltimore clinical trial?

To participate in a University of Maryland, Baltimore trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University of Maryland, Baltimore trials with current recruitment status updated daily.

University of Maryland, Baltimore

Frequently Asked Questions — University of Maryland, Baltimore

Clinical Trials by University of Maryland, Baltimore

Study of PLK1 Inhibitor, Onvansertib, in Relapsed Small Cell Lung Cancer

Selective Adjuvant Therapy for HPV-mediated Oropharynx SCCs Based on Residual Circulating Tumor DNA Levels (SAVAL)

PKD Clinical and Translational Core Study

Vallomix Socket Preservation Study

Pharmacogenetics of Response to GLP1R Agonists

The HOPE Study: Characterizing Patients With Hepatitis B and C

Blood Donor CVD 5000

Induction of Labor in Morbidly Obese Patients

Is Physical Therapy Clearance Before Arthroplasty Home Discharge Necessary?

Recovery Among Older Adults Following Mild TBI

GammaPod Registry and Quality of Life Nomogram

Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV

A Split-Mouth Clinical Trial Evaluating the Bond Failure Rate of a New Etch-Free Orthodontic Adhesive

Change in MAPSE During Treatment of Sepsis

TMS for Inhibition Enhancement in Schizophrenia

Hub-Based Engagement Navigator Service to Reduce CSC Disengagement

Acute Normovolemic Hemodilution on Urine Neutrophil Gelatinase-associated Lipocalin Levels